about
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population studyCardiomyopathy in patients with POMT1-related congenital and limb-girdle muscular dystrophy.Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors.Semi-synthetic derivatives of natural isoflavones from Maclura pomifera as a novel class of PDE-5A inhibitors.Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors.Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cellsEffect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.Antiproliferative activity of Juglone derivatives on rat glioma.New naphthoquinone derivatives against glioma cells.The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways.The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells.Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models.Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors.POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study.Immunological features of neurological paraneoplastic syndromes.The spectrum of antineuronal autoantibodies in a series of neurological patients.Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines.Functional significance of the novel H-RAS gene mutation M72I in a patient with medullary thyroid cancer.Sodium intake, sodium excretion, and cardiovascular risk: involvement of genetic, hormonal, and epigenetic factors.Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors.Adrenocortical carcinoma: where we stand.Phytotherapeutics in cancer invasion and metastasis.Programmed Cell Death, from a Cancer Perspective: An Overview.EF24 (a curcumin analog) and ZSTK474 emphasizes the effect of cabozantinib in medullary thyroid cancer.Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations.BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma.Effects of point mutations in the binding pocket of the mouse major urinary protein MUP20 on ligand affinity and specificityThe Therapeutic Potential of Naringenin: A Review of Clinical TrialsNovel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer PatientsSynergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective.The natural history of autoimmune Addison's disease with a non-classical presentation: a case report and review of literatureRelationship between sodium, pentraxin-3 and aldosterone in inflammation and cardiovascular riskNew targeted therapies for adrenocortical carcinomasMicroRNA Expression Profiling in Adrenal MyelolipomaThe effects of mitotane and 1α,25-dihydroxyvitamin D3 on Wnt/beta-catenin signaling in human adrenocortical carcinoma cellsErythrina suberosa: Ethnopharmacology, Phytochemistry and Biological ActivitiesCirculating miRNA Expression Profiling in Primary AldosteronismLiposomal Cytarabine as Cancer Therapy: From Chemistry to MedicineADRENOCORTICAL CARCINOMA: IN THE SEARCH FOR A PRE-OPERATIVE BIOMARKER
P50
Q28238656-9030567D-C00A-405B-BB24-B2E2B475C77EQ30446533-F67C8D46-71FE-4953-A6DB-70B58096E107Q33905628-427CEDFA-5626-4BFE-9830-4456EB6593B9Q34483283-2919ACA0-752E-4C6C-AA03-5F0522035873Q36029393-4482E97B-6051-4A7E-A13F-578B9CE2A94CQ36057504-0F97CC11-1B20-4F63-A6D7-C81C16657DE3Q36134732-740B9CE5-DBC6-4D0C-B61C-46042CF09F54Q38755318-9404AAA9-626F-4A61-8B21-7174793F3C32Q38881820-D4D7BC3E-B9C8-47FB-A4BA-F5DA1C610FD6Q38995628-DF55ED99-B91F-4F1E-8784-315140686A9DQ39072528-4F93FA89-00EC-4A01-9CBD-FBFFDBD5C8C1Q39335975-8DEDCA2C-9FB0-421B-8D46-48DEE72EC887Q39549740-94BE8216-80C5-4E10-81F2-D8EC3CC02B68Q40356966-CFBF83C6-F43D-4AF1-B413-C7213224DB4FQ41939145-BB6567EF-6015-476B-83E2-BA3986D2C3B8Q47409536-4E687E1F-676B-452C-A77B-173547F0C1B4Q47612045-BEEC9A96-BB57-4F97-9F91-D1D28559094FQ47656877-D4D3484D-F26B-46D6-B72A-9BEE6D0F288FQ47807194-DE642352-60A2-4568-970B-1E527C996C2EQ48152245-5CE8F135-AC28-4416-AC7F-1D28E2AEB628Q48311865-E564BAEA-60F7-48C5-A98E-6F87694F40A5Q50015470-FDEE6105-2090-460F-B107-34109E39CD3DQ52315531-5FD7DBCB-CEC7-4E2C-ACC3-5EC0405CB9B4Q52348330-3BA4E349-57F0-4A7E-B06F-3BFF0A4D0412Q52717083-F10CC77B-CECA-496C-B13D-B9E6140C44EEQ54393196-BF748A60-0728-4B99-AE11-C4A583981743Q54545918-9B75F239-8FE8-473A-9D76-4DCDE5D9DC40Q61445606-5308421D-5E03-4541-8AAF-9F651D5BA3F1Q64230467-387A768D-B66C-42DD-8323-0A3384532C83Q64235452-067E55B6-47A8-4ABA-BC5F-276FBFD5E534Q64994715-8BAB9854-31DD-4CCD-9E12-5BA93EC99FB8Q87871218-B1977AF8-F81A-4E5A-AF91-B18839360DB4Q88490368-81CBAA32-4FD4-4F08-A7E9-01A7C19FE162Q88887756-D0103B80-9D69-48AE-B1D3-273651DDD353Q89457882-7A66F7D2-0449-407D-A5EE-79D7955AB540Q90513584-2A25D6AF-5D2C-48EE-9055-BFC62C3443F0Q90852556-28E08269-45F1-4E98-9A76-794285739F14Q91316540-B96E01C9-A25D-45DD-B6A6-C314AF3C2467Q91468894-0105B50C-867C-44B9-A02A-F98E02F30D48Q92432017-53D92CE6-2CF5-4A71-A851-E4AA2450D867
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Raffaele Pezzani
@ast
Raffaele Pezzani
@en
Raffaele Pezzani
@es
Raffaele Pezzani
@nl
type
label
Raffaele Pezzani
@ast
Raffaele Pezzani
@en
Raffaele Pezzani
@es
Raffaele Pezzani
@nl
prefLabel
Raffaele Pezzani
@ast
Raffaele Pezzani
@en
Raffaele Pezzani
@es
Raffaele Pezzani
@nl
P106
P21
P31
P496
0000-0003-3156-2500